{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:10:50Z","timestamp":1781629850485,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Animal models, particularly mouse models, are indispensable for understanding the pathogenic mechanisms and developing therapeutic and diagnostic drugs for Alzheimer\u2019s diseases (AD). While most AD mouse models aim to mimic amyloid-\u03b2 (A\u03b2) pathology in their brains, previous research has demonstrated that not all models succeed in reproducing A\u03b2 fibril structures observed in the brains of AD patients. In this study, we determined cryo-electron microscopy (cryo-EM) structures of A\u03b2 fibrils extracted from the brains of two AD models, 5xFAD and App\n                    <jats:sup>NL\u2212F<\/jats:sup>\n                    Psen1\n                    <jats:sup>P117L<\/jats:sup>\n                    . The former represents one of the most widely used transgenic AD models, while the latter is the third-generation knock-in model designed to address the issues arising from\n                    <jats:italic>App<\/jats:italic>\n                    overexpression in conventional models. Our results revealed that fibrils from the 5xFAD mouse exhibit a structure nearly identical to human Type II A\u03b2 fibrils found in AD patients, whereas the App\n                    <jats:sup>NL\u2212F<\/jats:sup>\n                    Psen1\n                    <jats:sup>P117L<\/jats:sup>\n                    mouse predominantly possesses Type II A\u03b2 fibrils but also contains another A\u03b2 fibril species. A subtle discrepancy in main chain arrangement at the position of Val36 was noted among all reported human and mouse Type II structures, potentially originating from variations in the brain microenvironment between human and mice. In conclusion, our findings validated the replication of A\u03b2 pathology in 5xFAD and App\n                    <jats:sup>NL\u2212F<\/jats:sup>\n                    Psen1\n                    <jats:sup>P117L<\/jats:sup>\n                    mice and provide additional options for selecting appropriate animal models in studies necessitating molecular-level replication of A\u03b2 structures.\n                  <\/jats:p>","DOI":"10.1186\/s13024-026-00924-6","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:47:03Z","timestamp":1768038423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The molecular fidelity of A\u03b2 pathology in 5xFAD and AppNL\u2212FPsen1P117L mice revealed by cryo-EM"],"prefix":"10.1186","volume":"21","author":[{"given":"Meinai","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanrun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianting","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"924_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, et al. Alzheimer\u2019s disease. Lancet Lond Engl. 2016;388:505\u201317.","journal-title":"Lancet Lond Engl"},{"key":"924_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312\u201339.","journal-title":"Cell"},{"key":"924_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM, Protein Misfolding. Amyloid Formation, and human disease: A summary of progress over the last decade. Annu Rev Biochem. 2017;86:27\u201368.","journal-title":"Annu Rev Biochem"},{"key":"924_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science"},{"key":"924_CR5","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"G Chen","year":"2017","unstructured":"Chen G, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38:1205\u201335.","journal-title":"Acta Pharmacol Sin"},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.bbrc.2019.01.124","volume":"510","author":"Y Lin","year":"2019","unstructured":"Lin Y, Im H, Diem LT, Ham S. Characterizing the structural and thermodynamic properties of A\u03b242 and A\u03b240. Biochem Biophys Res Commun. 2019;510:442\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"924_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.abm7285","volume":"375","author":"Y Yang","year":"2022","unstructured":"Yang Y, et al. Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains. Science. 2022;375:167\u201372.","journal-title":"Science"},{"key":"924_CR8","doi-asserted-by":"crossref","unstructured":"Zhao Q, et al. Unraveling Alzheimer\u2019s complexity with a distinct A\u03b242 fibril type and specific AV-45 binding. Nat Chem Biol. 2025;1\u20139.","DOI":"10.1038\/s41589-025-01921-4"},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, et al. Lecanemab in early alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, et al. Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512\u201327.","journal-title":"JAMA"},{"key":"924_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMp1208061","volume":"367","author":"L Yang","year":"2012","unstructured":"Yang L, Rieves D, Ganley C. Brain amyloid Imaging \u2014 FDA approval of Florbetapir F18 injection. N Engl J Med. 2012;367:885\u20137.","journal-title":"N Engl J Med"},{"key":"924_CR12","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, et al. APP mouse models for alzheimer\u2019s disease preclinical studies. EMBO J. 2017;36:2473\u201387.","journal-title":"EMBO J"},{"key":"924_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","volume":"19","author":"MZ Zhong","year":"2024","unstructured":"Zhong MZ, Peng T, Duarte ML, Wang M, Cai D. Updates on mouse models of alzheimer\u2019s disease. Mol Neurodegener. 2024;19:23.","journal-title":"Mol Neurodegener"},{"key":"924_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00401-022-02533-1","volume":"145","author":"Y Yang","year":"2023","unstructured":"Yang Y, et al. Cryo-EM structures of amyloid-\u03b2 filaments with the Arctic mutation (E22G) from human and mouse brains. Acta Neuropathol (Berl). 2023;145:325\u201333.","journal-title":"Acta Neuropathol (Berl)"},{"key":"924_CR15","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41593-023-01484-4","volume":"26","author":"M Zielinski","year":"2023","unstructured":"Zielinski M, et al. Cryo-EM of A\u03b2 fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic alzheimer\u2019s disease. Nat Neurosci. 2023;26:2073\u201380.","journal-title":"Nat Neurosci"},{"key":"924_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T. Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol (Berl). 2017;133:155\u201375.","journal-title":"Acta Neuropathol (Berl)"},{"key":"924_CR17","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/d41586-018-05722-9","volume":"559","author":"A King","year":"2018","unstructured":"King A. The search for better animal models of alzheimer\u2019s disease. Nature. 2018;559:S13\u20135.","journal-title":"Nature"},{"key":"924_CR18","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, et al. Intraneuronal \u03b2-Amyloid Aggregates, Neurodegeneration, and neuron loss in Transgenic mice with five Familial alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"924_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, et al. Single app knock-in mouse models of alzheimer\u2019s disease. Nat Neurosci. 2014;17:661\u20133.","journal-title":"Nat Neurosci"},{"key":"924_CR20","doi-asserted-by":"publisher","first-page":"101004","DOI":"10.1016\/j.jbc.2021.101004","volume":"297","author":"K Sato","year":"2021","unstructured":"Sato K, et al. A third-generation mouse model of alzheimer\u2019s disease shows early and increased cored plaque pathology composed of wild-type human amyloid \u03b2 peptide. J Biol Chem. 2021;297:101004.","journal-title":"J Biol Chem"},{"key":"924_CR21","doi-asserted-by":"crossref","unstructured":"Qi C, et al. Tau filaments from amyotrophic lateral sclerosis\/parkinsonism-dementia complex adopt the CTE fold. Proc Natl Acad Sci U S A. 2023;120:e2306767120.","DOI":"10.1073\/pnas.2306767120"},{"key":"924_CR22","doi-asserted-by":"crossref","unstructured":"Stern AM, et al. Abundant A\u03b2 fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer\u2019s disease brains. Neuron. 2023;111:2012-2020.e4.","DOI":"10.1016\/j.neuron.2023.04.007"},{"key":"924_CR23","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, et al. Two amyloid precursor protein Transgenic mouse models with alzheimer disease-like pathology. Proc Natl Acad Sci. 1997;94:13287\u201392.","journal-title":"Proc Natl Acad Sci"},{"key":"924_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2004.12.007","volume":"27","author":"A Lord","year":"2006","unstructured":"Lord A, et al. The Arctic alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in Transgenic mice. Neurobiol Aging. 2006;27:67\u201377.","journal-title":"Neurobiol Aging"},{"key":"924_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14:331\u20132.","journal-title":"Nat Methods"},{"key":"924_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus Estimation from electron micrographs. J Struct Biol. 2015;192:216\u201321.","journal-title":"J Struct Biol"},{"key":"924_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres SHW, RELION. Implementation of a bayesian approach to cryo-EM structure determination. J Struct Biol. 2012;180:519\u201330.","journal-title":"J Struct Biol"},{"key":"924_CR28","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler T, et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat Methods. 2019;16:1153\u201360.","journal-title":"Nat Methods"},{"key":"924_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1107\/S2059798318005119","volume":"74","author":"P Emsley","year":"2018","unstructured":"Emsley P, Crispin M. Structural analysis of glycoproteins: Building N-linked glycans with Coot. Acta Crystallogr Sect Struct Biol. 2018;74:256.","journal-title":"Acta Crystallogr Sect Struct Biol"},{"key":"924_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine PV, et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr Sect Struct Biol. 2018;74:531\u201344.","journal-title":"Acta Crystallogr Sect Struct Biol"},{"key":"924_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams CJ, et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 2018;27:293\u2013315.","journal-title":"Protein Sci Publ Protein Soc"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00924-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:33:23Z","timestamp":1781627603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00924-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00924-6","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"5xFAD experiments received ethical and scientific approval from Shanghai Jiao Tong University and strictly adhered to the animal care regulations of the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University. App\n                      NL\u2212F\n                      Psen1\n                      P117L\n                      experiments received ethical and scientific approval from the Kunming Institute of Zoology and strictly adhered to the animal care regulations of the Institutional Animal Care and Use Committee of Kunming Institute of Zoology, Chinese Academy of Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}